Podcasts about nyu langone health

What if there was literally a plastic spoon's worth of microplastics sitting inside your brain right now? In this jaw-dropping and deeply urgent solo episode, Darin Olien breaks down the newest science on microplastics, nanoplastics, brain accumulation, neuroinflammation, endocrine disruption, and the rapidly escalating contamination of the human body. Referencing groundbreaking new research published in Nature Medicine and newly launched U.S. government initiatives, Darin exposes how plastics are no longer just an environmental issue—they are now a human biology issue. From nanoplastics crossing the blood-brain barrier to endocrine-disrupting chemicals like BPA, PFAS, and phthalates accumulating in tissues, placentas, and testes, this episode explores the shocking implications of modern plastic exposure—and, more importantly, what practical steps you can take immediately to reduce your risk.     What You'll Learn The shocking new study finding microplastics in 100% of healthy human brains Why the average brain may now contain roughly a plastic spoon's worth of plastic How nanoplastics cross the blood-brain barrier The alarming connection between microplastics and dementia research Why plastics are not biologically inert substances The endocrine-disrupting chemicals hitchhiking on microplastics How bottled water, tea bags, coffee pods, and heated plastics dramatically increase exposure The role of PFAS, BPA, phthalates, and flame retardants in human health decline Why reverse osmosis filtration is one of the most effective protective tools Practical ways to reduce microplastic exposure immediately     Chapters 00:00:03 – Welcome to SuperLife 00:00:33 – Sponsor: Alkemis wellness paint and indoor air toxicity 00:00:57 – Conventional paints, endocrine disruptors, and off-gassing chemicals 00:01:24 – VOC-free mineral paints and PFAS-free home environments 00:01:55 – Fire resistance, sustainability, and Cradle to Cradle certification 00:02:53 – Why the products surrounding us matter biologically 00:03:23 – New study finds microplastics in 100% of healthy human brains 00:03:44 – The U.S. government launches a $144 million microplastics initiative 00:03:52 – Visualizing a plastic spoon's worth of plastic in the brain 00:04:22 – The Nature Medicine findings explained 00:04:40 – Dementia brains containing dramatically more plastic accumulation 00:04:47 – Why this study is not "internet noise" 00:05:07 – Dr. Matthew Campen and the University of New Mexico research 00:05:15 – The STOMP program: Systemic Targeting of Microplastics 00:05:45 – From environmental issue to "inside your body" crisis 00:06:01 – What listeners will learn and actionable solutions 00:06:21 – Breaking down the Campen study in detail 00:06:38 – Gas chromatography mass spectrometry analysis explained 00:06:50 – Roughly seven grams of plastic found in average brains 00:07:09 – Brain tissue containing more plastic than liver or kidneys 00:07:21 – Dementia brains showing 10x more plastic concentration 00:07:28 – Nanoplastics crossing the blood-brain barrier 00:07:42 – The alarming acceleration of accumulation rates 00:08:03 – Healthy brains vs diseased brains and microplastic prevalence 00:08:24 – The unanswered question: dose and biological effect 00:08:40 – Correlation vs causation and scientific uncertainty 00:09:06 – Why the trend itself is deeply concerning 00:09:23 – Plastic accumulation in blood vessel walls and immune cells 00:09:46 – Chronic neuroinflammation and cognitive decline 00:09:56 – Plastics carrying phthalates, BPA, PFAS, and flame retardants 00:10:08 – Endocrine disruption and hormone interference 00:10:19 – Plastics found in placentas and testes 00:10:31 – "Structural pollution of the human body" 00:10:52 – The plastic industry externalizing costs onto humanity 00:10:58 – Practical steps listeners can take immediately 00:11:02 – Why bottled water may be a major source of nanoplastics 00:11:28 – Reverse osmosis filtration and reducing exposure 00:11:46 – AquaTru systems and affordable filtration solutions 00:12:09 – Sponsor: Shakeology and nutrient density 00:13:58 – Stop heating food in plastic immediately 00:14:17 – Heat dramatically increasing microplastic transfer into food 00:14:31 – Switching to glass, stainless steel, and ceramic containers 00:14:50 – Dangerous recycling codes and plastic leaching 00:15:13 – The hidden plastic problem inside tea bags 00:15:27 – One tea bag releasing billions of microplastics into tea 00:15:50 – Why Darin says to ditch plastic tea bags completely 00:16:02 – Loose leaf tea and stainless steel infusers 00:16:14 – Coffee pod machines and heated plastics under pressure 00:16:26 – Safer coffee alternatives: French press and pour-over 00:16:38 – Fiber helping bind and eliminate particulate matter 00:17:00 – Sweating, exercise, and toxin mobilization 00:17:22 – Polyphenols and antioxidant-rich foods 00:17:42 – Broccoli sprouts, sulforaphane, and glutathione support 00:18:24 – Omega-3s and reducing neuroinflammation 00:18:34 – The plastic industry's "safe and recyclable" narrative 00:18:58 – Comparing plastics to tobacco and PFAS deception 00:19:16 – Disposable convenience culture and "fatal conveniences" 00:19:45 – The simplest immediate change: replacing tea bags 00:20:10 – Taking sovereignty back through everyday choices 00:20:34 – Patreon deep dives and continuing the conversation 00:20:53 – "Your body is not a landfill" 00:21:08 – Why small daily choices compound biologically 00:21:22 – Final reflections and closing thoughts     Thank You to Our Sponsors Shakeology: Get 15% off with code DARINO1BODI at Shakeology.com. Alkemis: Go to https://alkemispaint.com/ and use code DARIN10 for 10% off your order.     Join the SuperLife Patreon: This is where Darin now shares the deeper work: - weekly voice notes - ingredient trackers - wellness challenges - extended conversations - community accountability - sovereignty practices Join now for only $7.49/month at https://patreon.com/darinolien     Connect with Darin Olien: Website: darinolien.com Instagram: @darinolien Book: Fatal Conveniences Platform & Products: superlife.com New Show: Roadmap to Happiness     Key Takeaway "Microplastics are no longer just floating in oceans or polluting landfills—they are accumulating inside human beings. Inside our brains. Inside our blood vessels. Inside unborn children. But while the scale of the problem is staggering, the solution begins with everyday choices. What you drink from. What you heat your food in. What you filter. What you buy. Your body is not a landfill—and reclaiming your health starts with refusing to treat it like one."     Bibliography/Sources Primary Scientific Studies Bornstein, S. R., et al. (2025). Therapeutic apheresis: A promising method to remove microplastics? Brain Medicine . https://pmc.ncbi.nlm.nih.gov/articles/PMC12162106/ Campen, M., et al. (2025). Bioaccumulation of microplastics in decedent human brains. Nature Medicine . https://pmc.ncbi.nlm.nih.gov/articles/PMC11100893/ Campen, M., et al. (2026). Microplastics in 100% of healthy brain samples (2026 Update) . https://hsc.unm.edu/news/2024/05/microplastics-accumulate-in-brain.html Hernandez, L. M., et al. (2019). Plastic teabags release billions of microparticles and nanoparticles into tea. Environmental Science & Technology, 53(21), 12300–12310 . https://pubs.acs.org/doi/10.1021/acs.est.9b02540 Government & University Announcements Advanced Research Projects Agency for Health (ARPA-H). (2026, April 2). STOMP program launch . https://arpa-h.gov/explore-funding/programs/stomp U.S. Department of Health and Human Services (HHS). (2026, April 2). HHS press release on STOMP . https://arpa-h.gov/explore-funding/programs/stomp University of New Mexico Health Sciences Center. (n.d.). UNM HSC announcement - Microplastics in human brains . https://hsc.unm.edu/news/2024/05/microplastics-accumulate-in-brain.html Health & News Resources EurekAlert! (n.d.). Micronanoplastics found in artery-clogging plaque in the neck . https://www.eurekalert.org/news-releases/1080866 NYU Langone Health. (n.d.). 7 ways to reduce your exposure to microplastics . https://nyulangone.org/news/7-ways-reduce-your-exposure-microplastics

Dr. Mahya Beheshti is a physician-scientist at Rusk Rehabilitation, NYU Langone Health, where she works at the intersection of medicine and engineering to advance neurorehabilitation and assistive technologies. Her research focuses on neurorehabilitation, human–machine interfaces, EEG-based pattern recognition, and wearable technologies. She is particularly interested in how eye–hand coordination and multimodal neurophysiological signals can inform the development of intelligent rehabilitation systems for individuals with stroke, multiple sclerosis, and vision impairment. Fascinated by the powerful synergy between medicine and engineering, she earned her medical degree from Gulf Medical University and she is pursuing a part-time Ph.D. in mechanical and aerospace engineering while continuing her clinical and scientific work at Rusk. The discussion included the following topics: reason for choosing to do research in the area of visual impairment rehabilitation; research involving centers on sensory–motor coordination; key research findings; what is missing when doing traditional motor control assessments; how subtle timing disruptions between the eyes and hands affect daily functioning; and new investigations that may be undertaken in the next 12 months.

The Baby Boom generation pioneered the counterculture movement of the 1960s so it's not so surprising that 50 years later they are using compounds like psilocybin and LSD with the goal to improve their overall quality of life. ​Today, we get into all of the above with Abbie Rosner, the author of the forthcoming book “Psychedelics and the Counterculture of Aging.” She researches and writes about how her generation of Baby Boomers is exploring the drugs of their youth to enhance their experience of aging. In "Psychedelics and the Counterculture of Aging," she suggests that the growing underground movement of older adults using psychedelics is helping rewrite the narrative around aging —as a time of healing, growth, spiritual deepening, joyous intimacy, supportive community, and acceptance of the inevitability of death. Abbie is a freelance journalist, writer, and public speaker based out of Washington, D.C., and she has written extensively on older adults, cannabis, and psychedelics for Forbes, Double Blind, and other journals since 2018. Her new book comes out in July 2026. ◘ Related Links Abbie Rosner's website https://www.abbierosner.com/ Johns Hopkins Center for Psychedelic and Consciousness Research https://www.hopkinspsychedelic.org/ NYU Langone Health's Center for Psychedelic Medicine https://bit.ly/4dvwAG6 UC Berkeley Center for the Science of Psychedelics https://psychedelics.berkeley.edu/ GW Integrative Medicine Podcast Medical Cannabis, Psilocybin, & More Playlist https://bit.ly/3RO8q0Z ◘ Transcript bit.ly/3JoA2mz ◘ Disclaimer: The content and information shared in GW Integrative Medicine is for educational purposes only and should not be taken as medical advice. The views and opinions expressed in GW Integrative Medicine represent the opinions of the host(s) and their guest(s). For medical advice, diagnosis, and/or treatment, please consult a medical professional.

In this episode live from Hawaiian Eye 2026, Cathleen McCabe, MD speaks with Marguerite McDonald, MD, FACS about her fascinating career that has spanned many decades. From shocking stories about ophthalmic research to being the first woman to pioneer a number of leadership roles in the field, Dr. McDonald shares her journey.  We'd love to hear from you! Send your comments/questions to podcast@healio.com. Follow us on Twitter @Healio_OSN. Mend the Gap would also like to give you the chance to nominate yourself or a colleague for a travel grant! To enter, simply email us at podcast@healio.com! ·        Welcome to this episode 1:23 ·        Marguerite McDonald, MD, FACS 1:35 ·        Tell us about your career, how did you start? 4:30 ·        How did you become the first person in the world to perform corneal refractive surgery? 9:27 ·        Radial keratotomy and a lawsuit 16:07 ·        Refractive surgery research 20:10 ·        Facing criticism 29:13 ·        Any motivating words for our audience? 35:12 ·        Thank you! 37:34 Cathleen McCabe, MD, is chief medical officer of Eye Health America and medical director of The Eye Associates in Sarasota, Florida. Marguerite McDonald, MD, FACS, is a clinical professor of ophthalmology at NYU Langone Health and in private practice with OCLI in Long Island, NY.

Today, I have the honor of interviewing Dr. Doris Day, a board-certified dermatologist who specializes in cosmetic and longevity dermatology. She is also a clinical professor of dermatology at NYU, recognized for her dedication and excellence in teaching, and is widely regarded as a leader in the aesthetic dermatology field. In addition to her clinical work, Dr. Day is a medical journalist and a prominent media figure. In our discussion, we examine the basics of perimenopause and menopause from a pathophysiology perspective, including the 30% decline in collagen synthesis that occurs during the first five years of menopause. We explore the skin microbiome, inflammation, and inflammaging, and why hydration, electrolytes, reducing processed sugars, and eating a nutrient-dense diet can have such a visible impact on skin health. Dr. Day also explains her approach to facial balancing and how our bones, fascia, muscles, and fat pads age. We discuss topical agents, advanced interventions including lasers, microneedling, PRF, PRP, stem cells, and growth factors, and even touch on emerging research suggesting that certain laser treatments may help reduce the risk of skin cancer. Throughout the conversation, I also openly shared what I have done to support my skin. Stay tuned for today's fascinating conversation about menopause, skin health, collagen loss, and the evolving science behind modern aesthetic dermatology. IN THIS EPISODE, YOU WILL LEARN: The sudden skin changes many women experience during early perimenopause Dr. Day explains how she personalizes skincare routines for each patient How collagen synthesis rapidly declines during the menopause transition How hydration, sleep, and nutrition can visibly improve skin tone and puffiness How inflammation, blood sugar issues, and poor metabolic health contribute to inflammaging and visible skin aging Why facial balance is more important than trying to erase every wrinkle or line Dr. Day shares how she combines lasers, topicals, and recovery protocols to support skin healing and collagen production How fillers and other cosmetic procedures can create an unnatural appearance when used incorrectly Bio: Dr. Doris Day, MD, is a board-certified dermatologist specializing in cosmetic and longevity dermatology. She is a Clinical Professor of Dermatology at NYU Langone Health, where she has been recognized with the Award for Dedication and Excellence in the Teaching of Dermatology. Her leadership in aesthetic dermatology has earned her the AAD Presidential Citation and the American Skin Association Award for leadership in dermatology. Ranked #3 in the United States and #1 in New York by Newsweek as a Top Cosmetic Dermatologist, Dr. Day is a recognized authority in her field. Her work has been cited in leading publications, including The New York Times and Castle Connolly's NY Magazine Top Doctors listings, for over 20 consecutive years. Dr. Day is also a medical journalist and a prominent media figure, providing expert commentary on major television programs and podcasts. Her insights are regularly featured in top magazines, and she is a sought-after speaker, delivering numerous lectures every year on cutting-edge aesthetic techniques at both national and international conferences. Dr. Day has over 100 publications in the medical literature, and she has written four best-selling books: "Rebooting the Biome" (2023), "Beyond Beautiful" (2018), "Forget the Facelift," and "100 Questions and Answers about Acne." She also hosts a popular dermatology show on SiriusXM's Doctor Radio, a platform where she has been educating the public for over 15 years, earning the AAD's Golden Triangle Award for Media Excellence. Her professional affiliations include the American Society for Dermatologic Surgery, where she has served on the board of directors; the American Academy of Dermatology, where she was recently elected to the nominating committee; the New York State Dermatology Society; and the American Honors Society of Dental and Facial Aesthetics. Dr. Day earned her BA in English from Columbia University, an MA in Journalism and Science Writing/Medical Reporting from New York University, and her MD from SUNY Downstate College of Medicine. She completed her dermatology residency at Cornell University College of Medicine, where she served as Chief Resident. Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website. Submit your questions to support@cynthiathurlow.com  Join other like-minded women in a supportive, nurturing community: The Midlife Pause/Cynthia Thurlow.  Cynthia's Menopause Gut Book is on presale now! Cynthia's Intermittent Fasting Transformation Book The Midlife Pause Supplement Line Connect with Dr. Doris Day On her website Instagram, Facebook, and TikTok

On this Thursday edition of Sid & Friends in the Morning, Sid reacts to a comment made by lawyer and former law professor Alan Dershowitz on this very station last night, saying Staten Island should secede from New York City and elect Sid as its Mayor to combat New York City and Mayor Zohran Mamdani. In other news of the day, Laura Loomer claims a source told her that Hochul and Mayor Mamdani are collaborating to ensure NYPD doesn't arrest protesters during this year's Israel Day Parade in Manhattan, NYU ​Langone Health - one of New York City's major hospital networks - said it received a federal grand jury ‌subpoena from the U.S. Department of Justice seeking information concerning gender-affirming care it provided to minors, Republican Rep. Mike Lawler of New York says he was approached at a bar by GOP Sen. Rand Paul's "inebriated" son - who made anti-Semitic comments toward him, President Trump landed in Beijing last evening local time to meet with Chinese President Xi Jinping at a crucial moment in Trump's presidency amid the war with Iran and uncertainty about the economy, and ex-New York Mets flamethrower Noah Syndergaard called Mayor Zohran Mamdani a “lunatic” and advised his former squad to “stop hanging out with socialist mayors” to end its on-field struggles. Alex Traiman, Bill O'Reilly, Cherie Devaux, Elizabeth Pipko, Mike Lawler & Suzanne Miller join Sid on this Friday-eve installment of Sid & Friends in the Morning. Learn more about your ad choices. Visit megaphone.fm/adchoices

In this episode of the Oncology Brothers podcast, we dived into the world of anti-EGFR therapies in non-small cell lung cancer (NSCLC). Joined by Dr. Joshua Sabari from NYU Langone Health and Dr. Azam Farooqui from Ironwood Cancer and Research Center, we discussed the latest advancements in treatment options, including the use of osimertinib, afatinib, and the combination therapy of amivantamab and lazertinib. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ Key topics include: The role of afatinib in treating uncommon EGFR mutations and its associated toxicities The well-tolerated profile of osimertinib and its common side effects, including rash, diarrhea, and the rare risk of pneumonitis Insights into the combination therapy of amivantamab and lazertinib, including management of skin toxicity and the importance of prophylactic anticoagulation to mitigate VTE risks The episode emphasized the importance of maintaining quality of life for patients while ensuring they can stay on effective therapies for longer periods. Tune in for valuable clinical pearls and strategies to optimize patient care in the community setting. Don't forget to like, subscribe, and check out our other episodes for more insights on treatment algorithms and conference highlights! #LungCancer, #NSCLC, #EGFR, #TargetedTherapy, #OncologyBrothers

This content has been funded by AstraZeneca, and is intended for healthcare professionals. The content in this podcast is for educational purposes only and is not intended to provide medical advice, diagnosis, or treatment, nor to promote any specific product or therapy.  The guests have been compensated by AstraZeneca for their participation. The views expressed are their own and do not necessarily reflect those of the AMJ or AstraZeneca. If you choose to act on information discussed here, you do so at your own discretion. Description: As homologous recombination deficiency (HRD) testing becomes increasingly embedded in ovarian cancer pathways, clinicians need clear, operational guidance. This episode brings together expert perspectives on selecting tests, understanding outputs, and integrating results into guideline-aligned care.  Learn: ·       HRD basics in plain language: what you're measuring and why ·       Test selection and reporting nuances that affect downstream decisions ·       Workflow design across oncology, pathology, and genetics ·       Applying results to maintenance strategies and patient conversations  Speakers: 1.     Rebecca Arend, Associate Director for Clinical Research, UAB O'Neal Comprehensive Cancer Center; Endowed Professor of Gynecologic Oncology, University of Alabama, USA. 2.   Thomas Krivak, Director, Division of Gynecologic Oncology; Chief Surgeon, West Penn Hospital, USA. 3.    Bhavana Pothuri, Gynecologic Oncologist, NYU Langone Health; Associate Professor, Department of Obstetrics and Gynecology, NYU Grossman School of Medicine, USA.

RAMS Ask a Chair Podcast - Moderated by: Amanda Ventura, MD, University of Cincinnati College of Medicine

Metabolic Health, Advanced Lipidology, and Preventing ASCVDLevel up your primary prevention game. Learn when ApoB, Lp(a), and CAC actually change management, how to spot cardiometabolic risk before diabetes declares itself, and how to make smarter lipid decisions beyond the standard panel. We're joined by Dr. Greg Katz, cardiologist and prevention expert at NYU Langone Health.Claim CME for this episode at curbsiders.vcuhealth.org!Patreon | Episodes | Subscribe | Spotify | YouTube | Newsletter | Contact | Swag! | CMEShow Segments Intro Primary Prevention & Metabolic Syndrome (Case 1) Beyond the Standard Lipid Panel When to Order ApoB How Lp(a) Changes Management (Case 2) Using CAC/CCTA in the Gray Zone Recognizing Early Cardiometabolic Risk CGMs, Wearables, and Signal vs Noise (Case 3) How to Talk to Patients About Risk Take-Home Points CreditsWritten and produced by Paul Wurtz MD. Show notes, cover art, and infographic also created by Paul Wurtz MD. Hosts: Matthew Watto MD, FACP; Paul Williams MD, FACP    Reviewer: Sai S Achi MD, MBA, FACP Showrunners: Matthew Watto MD, FACP; Paul Williams MD, FACP Technical Production: PodPaste Guest: Greg Katz MD DisclosuresDr. Katz reports no relevant financial disclosures. The Curbsiders report no relevant financial disclosures. Sponsor: DeleteMeGet 20% off your DeleteMe plan when you go to joindeleteme.com/CURB and use promocode CURB at checkout.Sponsor: Panacea Legal Visit Panacea.Legal  and use code CURB20 for 20% off contract review services.Sponsor: FIGSWe've teamed up with FIGS, and now Curbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX. Sponsor: Continuing Education CompanyFor Curbsiders listeners, there's a special offer: use promo code Curb30 for 30% off all online courses and webcasts. Visit CMEmeeting.org/curbsiders to learn more.  

In this episode, Dr. Osamah Choudhry, Co Founder and CEO of Medivis and neurosurgeon at NYU Langone Health, discusses the evolving role of artificial intelligence and augmented reality in spine and cranial surgery. He shares insights on FDA clearances, distribution strategy, and how next generation navigation technology is improving precision, efficiency, and patient outcomes.

In this episode, Dr. Osamah Choudhry, Co Founder and CEO of Medivis and neurosurgeon at NYU Langone Health, discusses the evolving role of artificial intelligence and augmented reality in spine and cranial surgery. He shares insights on FDA clearances, distribution strategy, and how next generation navigation technology is improving precision, efficiency, and patient outcomes.

En este episodio de Código Tumoral, la Dra. Julieta Gómez, oncóloga médica de México, conversa con la Dra. María de Jesús Medina Arellano, investigadora del Instituto de Investigaciones Jurídicas de la UNAM y especialista en bioética y regulación de biotecnologías, sobre los retos y dilemas éticos del uso compasivo de medicamentos en oncología. La dinámica del episodio se centra en un diálogo reflexivo e interdisciplinario que aborda el origen, fundamento y complejidad de esta figura excepcional, en la que convergen la urgencia clínica, la incertidumbre científica y la esperanza de pacientes con enfermedades graves y sin alternativas terapéuticas aprobadas. A lo largo de la conversación se plantean interrogantes clave sobre su naturaleza —¿tratamiento o investigación?—, el papel de los comités de ética, el consentimiento informado y la tensión entre autonomía, seguridad y eficacia.Durante la charla se expone que el uso compasivo surge como respuesta a necesidades reales de pacientes en situaciones límite, permitiendo el acceso excepcional a medicamentos aún en investigación, cuando no existen otras opciones ni posibilidad de ingresar a un ensayo clínico. Se subraya que no equivale a investigación clínica formal ni sustituye los ensayos controlados, aunque puede generar información relevante sobre seguridad. Se enfatiza la importancia de comités interdisciplinarios independientes, sin conflictos de interés, que evalúen proporcionalidad de riesgos y beneficios, supervisen el proceso de consentimiento informado y den seguimiento continuo a efectos adversos y posibles beneficios. Asimismo, se advierte sobre el riesgo de generar falsas expectativas o presionar indebidamente a las agencias regulatorias a partir de casos individuales exitosos. El episodio cierra destacando que la ética no debe apagar la esperanza, sino evitar que se transforme en engaño, recordando que la medicina debe garantizar dignidad antes que promesas de curación.Preguntas realizadas durante la grabación:¿De dónde surge o por qué surge el uso compasivo de medicamentos?Cuando se hace uso compasivo de medicamentos, ¿hablamos de un tipo de tratamiento o de investigación?De acuerdo con su experiencia internacional, ¿cuál es el proceso que debería realizarse en el uso compasivo de medicamentos?¿Quién debe realizar y validar el consentimiento informado en estos casos?Si el paciente responde favorablemente, ¿hasta cuándo se le debe garantizar el medicamento?¿Qué riesgos existen cuando los casos exitosos generan creencias infundadas sobre eficacia y aceleran procesos regulatorios? Fuentes de consulta recomendadas para médicos interesados en el tema:Grupo de trabajo Working Group on Compassionate Use & Preapproval Access (CUPA) de la Section of Medical Ethics de NYU Langone Health — comparte recursos sobre acceso compasivo y acceso previo a aprobación para productos médicos investigacionales, con publicaciones, educación y políticas relacionadas con el tema.2024 Annual Report de CUPA — reporte anual con información sobre miembros, investigaciones, actividades educativas y análisis ético-político del acceso compasivo y preapproval access.CUPACon 2026 — conferencia internacional sobre los retos éticos del acceso compasivo y preapproval access. Fecha de grabación: 22 de enero de 2026.Referencia:Este contenido se basa en la interpretación crítica de la evidencia científica disponible, así como en la experiencia clínica del o los ponentes como profesionales de la salud en instituciones de referencia.Para profundizar en los conceptos discutidos, se recomienda al profesional de la salud consultar literatura científica vigente, guías clínicas internacionales y la normatividad aplicable en su país.

The Monetization of Loneliness: A new study shows that Americans spend more on OnlyFans than on ChatGPT and The New York Times combined, suggesting the platform is monetizing deep-seated cultural loneliness.Manhattan Hospital Ends Youth Gender Treatments: Sean and Scott discuss reports on NYU Langone Health's decision to discontinue its transgender youth medical program following federal funding threats and proposed regulatory changes.Surprising UK Abortion Data: The discussion covers alarming new data from the UK revealing a significant increase in abortions, prompting a conversation on the ethical implications of "pills-by-post" policies.Lessons from Ben Sasse: Scott and Sean reflect on former Senator Ben Sasse's announcement regarding his terminal pancreatic cancer, drawing biblical lessons on mortality, legacy, and faith in the face of death.Listener Question: Investing with a Kingdom Perspective: In response to a listener question, Scott and Sean discuss how believers should approach financial investments by considering both ethical stewardship and the long-term impact on God's kingdom.==========Think Biblically: Conversations on Faith and Culture is a podcast from Talbot School of Theology at Biola University, which offers degrees both online and on campus in Southern California. Find all episodes of Think Biblically at: https://www.biola.edu/think-biblically. To submit comments, ask questions, or make suggestions on issues you'd like us to cover or guests you'd like us to have on the podcast, email us at thinkbiblically@biola.edu.

Did you know that every two seconds someone in the U.S. needs blood? In this episode of the BBANYS podcast, Dr. Victoria Costa of NYU Langone Health starts with some eye-opening statistics about blood donation, before outlining five of the top reasons to become a donor.Remember, when you donate, you're not just giving blood—you're giving hope.

Dr. Paul Testa, Chief Health Informatics Officer who helped create the About Me Initiative at NYU Langone Health, and Dr. Katherine Hochman, Director of Hospital Medicine at NYU Langone Health, who envisioned the initiative, discuss the benefits of encouraging patients to provide non-medical information. The goal is to help care teams see patients as whole people beyond their diagnoses and to give patients an opportunity to share interests, hobbies, and fun facts that can help build trust and meaningful human connections. This About Me Initiative is being expanded from inpatient care to outpatient settings, such as infusion centers. Paul explains, "The About Me section in our EHR Epic is something that NYU Langone developed with the inspiration of Dr. Hochman, and it's essentially a dedicated discreet space in the medical record to allow patients to declare themselves, allowing them to give them a space that is transparent to all the users of the electronic health record, which are many and vast in their rules. So let them articulate something beyond their disease process or their health. So often, we reduce records to pneumonia, a broken hip, or an infection. The patient is so much more than that, and patients want to share that with us. We know that from practicing for years, Kathy and I both know that the way you connect with patients is through a narrative. Our currency is narrative. This is a location where either a patient or, if they choose to defer, can have one of their nurses or care team members provide a small sample of who they are outside of the care environment."   Katherine elaborates, "So I'm a hospitalist. Every Tuesday, I come into 16 to 18 new patients. And at NYU Langone, our length of stay keeps getting shorter and shorter, which is fantastic for patients because we want to get them in and out of the hospital as quickly and as safely as possible. But by definition, if patients stay shorter and shorter, we don't have as much time to connect. So the About Me Initiative really kicks off that connection that Paul was talking about a second ago. So long ago, and this is how it started, I would tell my teams, slow down to speed up, get to know who this patient is before getting into the heart failure, the pneumonia, the COPD, and really try to establish a little bit of a connection and build trust." #NYULangone #PatientVoices #PatientCare #HealthcareInnovation #PatientExperience #HealthIT #EHR #EpicEHR #HumanConnection #HealthcareTransformation #PatientCentered #MedicalTechnology #DigitalHealth #EmpathyInMedicine  nyulangone.org Download the transcript here

Dr. Paul Testa, Chief Health Informatics Officer who helped create the About Me Initiative at NYU Langone Health, and Dr. Katherine Hochman, Director of Hospital Medicine at NYU Langone Health, who envisioned the initiative, discuss the benefits of encouraging patients to provide non-medical information. The goal is to help care teams see patients as whole people beyond their diagnoses and to give patients an opportunity to share interests, hobbies, and fun facts that can help build trust and meaningful human connections. This About Me Initiative is being expanded from inpatient care to outpatient settings, such as infusion centers. Paul explains, "The About Me section in our EHR Epic is something that NYU Langone developed with the inspiration of Dr. Hochman, and it's essentially a dedicated discreet space in the medical record to allow patients to declare themselves, allowing them to give them a space that is transparent to all the users of the electronic health record, which are many and vast in their rules. So let them articulate something beyond their disease process or their health. So often, we reduce records to pneumonia, a broken hip, or an infection. The patient is so much more than that, and patients want to share that with us. We know that from practicing for years, Kathy and I both know that the way you connect with patients is through a narrative. Our currency is narrative. This is a location where either a patient or, if they choose to defer, can have one of their nurses or care team members provide a small sample of who they are outside of the care environment."   Katherine elaborates, "So I'm a hospitalist. Every Tuesday, I come into 16 to 18 new patients. And at NYU Langone, our length of stay keeps getting shorter and shorter, which is fantastic for patients because we want to get them in and out of the hospital as quickly and as safely as possible. But by definition, if patients stay shorter and shorter, we don't have as much time to connect. So the About Me Initiative really kicks off that connection that Paul was talking about a second ago. So long ago, and this is how it started, I would tell my teams, slow down to speed up, get to know who this patient is before getting into the heart failure, the pneumonia, the COPD, and really try to establish a little bit of a connection and build trust." #NYULangone #PatientVoices #PatientCare #HealthcareInnovation #PatientExperience #HealthIT #EHR #EpicEHR #HumanConnection #HealthcareTransformation #PatientCentered #MedicalTechnology #DigitalHealth #EmpathyInMedicine  nyulangone.org  Listen to the podcast here

Lindsey Gurin, MD, discusses how clinicians can approach patients whose symptoms fall at the intersection of psychiatry and neurology. Drawing on her work with traumatic brain injury, PTSD, and persistent post-concussive symptoms, she explains why attempts to separate psychological trauma from neurological injury often obscure what patients actually need.The conversation explores identity disruption after brain injury, the unintended effects of rigid recovery timelines, and the importance of continuity in understanding symptoms over time. Dr. Gurin also discusses how neurodevelopmental traits such as ADHD shape vulnerability and treatment response, when stimulant medications can be appropriate after concussion, and why breaking complex presentations into treatable components often matters more than assigning a single diagnosis.Lindsey Gurin, MD, is Assistant Professor in the Departments of Neurology, Psychiatry, and Rehabilitation Medicine at NYU Langone Health, and Director of the Neurology/Psychiatry Residency Program.▶️ Watch Insights on Psychiatry on YouTube00:00 Brain Injury and Identity01:27 What Is the Psychiatry–Neurology Double Board?02:41 Why PTSD and TBI Overlap03:28 What “Shell Shock” Really Means06:00 When Concussion Symptoms Don't Go Away07:25 Life Before vs After Brain Injury08:46 ADHD as a Hidden Risk Factor10:28 Using Stimulants After Brain Injury12:40 Rethinking “Post-Concussion Syndrome”13:27 The Future of Neuropsychiatric CareThis episode is intended for psychiatrists and other clinicians caring for patients with complex neuropsychiatric presentations at the intersection of psychiatry and neurology.This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle

Michael Bogenschutz, MD, explains how psychedelic-assisted treatments may offer new options for patients with severe, treatment-refractory psychiatric conditions. He discusses why standard approaches often fall short for complex cases, how psychedelics like psilocybin and MDMA differ from conventional medications, and what careful screening and clinical structure make these treatments safe and effective.Drawing on randomized clinical trials and years of clinical experience, Dr. Bogenschutz describes how psychedelic treatments can produce durable symptom improvement in disorders such as alcohol use disorder and trauma-related conditions. He also explores unresolved scientific questions, including whether the psychedelic experience itself is necessary for therapeutic benefit.Michael Bogenschutz, MD, is Professor of Psychiatry and Director of the Center for Psychedelic Medicine at NYU Langone Health.▶️ Watch Insights on Psychiatry on YouTube00:00 A Remarkable Case: Sustained Sobriety After Psilocybin Treatment00:39 Introducing Dr. Michael Bogenschutz01:04 Why Psychiatry Is Re-Examining Psychedelics02:50 Safety, Screening, and Managing the Psychedelic Experience03:45 Landmark Trial: Psilocybin for Alcohol Use Disorder06:16 How Psychedelics Work: Neuroplasticity vs. Subjective Experience08:53 Can Non-Psychedelic Analogs Deliver the Same Benefits?11:47 MDMA, Fear Reduction, and Emotional Processing13:44 Who Benefits Most? A Composite of Treatment-Refractory Patients15:45 The Future of Psychedelic Psychiatry at NYUThis episode is intended for psychiatrists, mental health clinicians, and others interested in complex and treatment-resistant psychiatric conditions.This discussion is for educational purposes and does not substitute for individual clinical judgment or patient care. Senior Producer: Jon Earle

Renowned physician, author, and media medical expert Dr. Marc Siegel joins “Your Health First” for an in-depth conversation you won't want to miss. Dr. Siegel is a clinical professor of medicine at NYU Langone Health and a senior medical analyst for Fox News, where he has become a trusted voice in explaining complex medical issues to millions of viewers. Over the years, he has covered everything from global pandemics to everyday health concerns, always with a focus on translating cutting-edge science into practical guidance for patients and families.In this episode, we dive into his latest book, Miracles Among Us, a compelling exploration of extraordinary recoveries, unexpected turnarounds, and the powerful intersection of science, faith, and the human spirit. Dr. Siegel shares the stories behind some of the most remarkable cases he's encountered—illustrating how resilience, medical innovation, and sometimes the inexplicable can shape outcomes in ways that defy expectation. The book not only highlights “miraculous” moments in medicine but also underscores the importance of hope, empathy, and connection in the healing process.Beyond the book, we tackle several of today's most urgent health topics, including the obesity epidemic, fatty liver disease, and the changing landscape of nutrition guidance—what some are calling the “new food pyramid.” Dr. Siegel also weighs in on the rapidly growing use of GLP-1 agonist medications and their role in combating chronic disease and obesity, discussing both their promise and their limitations. Tune in to hear a wide-ranging, insightful discussion that blends storytelling, science, and practical advice to help you better understand your health and the future of medicine.Where to find Dr. Joe Galati and his team:Dr. Galati's newsletter sign-upMedical Practice: Liver Specialists of TexasDr. Galati's Book Site: Eating Yourself SickFacebook: Dr. Joe GalatiDr. Galati's YouTube ChannelPlease send feedback and suggestion. You can message me here. Hosted on Acast. See acast.com/privacy for more information.

The endocrine system consists of eight major organs that produce and regulate hormones, the chemical messengers that keep the body in balance. Hormones quietly orchestrate everything from our energy and metabolism to mood, sleep, and resilience, acting as an internal communication network that responds to stress, environment, and lifestyle. From cold plunges and saunas to endocrine-disrupting chemicals, even small daily inputs are said to shift this delicate signaling. How does stress really affect our bodies? Does “adrenal fatigue” exist? Is it actually possible to “biohack” our hormones?In this episode, we are joined by Dr. Priya Jaisinghani, MD, ABIM, DABOM, a triple board-certified Endocrinology, Obesity Medicine, and Internal Medicine physician from New York City.Dr. Jaisinghani received her MD from Rutgers/Robert Wood Johnson Medical School, where she also completed her Internal Medicine Residency, Endocrinology and Obesity Medicine Fellowships at Weill Cornell Medicine. Currently, Dr. Jaisinghani is a Diabetes, Metabolism, and Obesity Medicine attending physician at NYU Langone Health, Clinical Assistant Professor of Medicine at NYU Grossman School of Medicine, and a Medical Unit Contributor at ABC News.Dr. Jaisinghani has been featured on CNN, Rolling Stone, The New York Times, The Wall Street Journal, Men's Health, FOX 5 News, and Medscape,Follow Friends of Franz Podcast: Website, Instagram, FacebookFollow Christian Franz (Host): Instagram, YouTube

Bipolar depression and mixed episodes remain among the most difficult—and highest-risk—conditions in psychiatry. Even when mood symptoms improve, many patients continue to experience significant cognitive and functional impairment.On NYU Insights on Psychiatry, Dan Iosifescu, MD, explains why standard treatment approaches so often fall short. Dr. Iosifescu argues that symptom suppression is frequently mistaken for recovery, that short-term improvement does not equal durable treatment, and that bipolar mixed episodes expose the limits of one-size-fits-all care.The discussion focuses on the clinical dangers of mixed episodes, the challenge of recognizing them, and the importance of acute stabilization followed by a deliberate transition to sustainable long-term treatment. Dr. Iosifescu also explores how emerging biological research—including metabolic interventions and personalized experimental models—may eventually help clinicians better match patients to treatments.Rather than offering quick fixes, this conversation reframes how clinicians think about success, recovery, and personalization in the treatment of bipolar depression.Guest: Dan Iosifescu, MD, Director of Clinical Research at the Nathan Kline Institute and Director of the Mood Disorders Clinical and Research Program at NYU Langone Health.Watch Insights on Psychiatry on YouTubeSenior Producer: Jon Earle

Joshua Berman, MD, PhD, discusses how careful evaluation, patient priorities, and risk-benefit tradeoffs guide the use of interventional treatments when conventional approaches fall short. Dr. Berman also explains how tools such as ketamine, TMS, ECT, and neurofeedback can be used strategically—sometimes in sequence or combination—to address different vulnerabilities within mood-related brain circuits.Dr. Berman is Associate Professor of Psychiatry and Director of Interventional Psychiatry at NYU Langone Health.TopicsEvaluating patients who have not improved with medications or psychotherapyThe limitations of existing treatment guidelines for complex casesWhen and why sequencing or combining interventions may be appropriateEmerging approaches such as EEG-guided neurofeedback and focused ultrasoundBuilding a comprehensive, patient-centered interventional psychiatry programThis episode offers a clinician-level perspective on how interventional psychiatry is practiced today, and how new technologies may expand options for patients with the most challenging presentations.Chapters00:00 Introduction: Caring for Patients Who Don't Respond to Standard Treatment00:47 What Is Interventional Psychiatry?02:33 Evaluating Treatment-Resistant Presentations06:31 Precision, Patient Priorities, and Clinical Judgment09:35 Sequencing and Combining Interventions10:40 Limits of Treatment Guidelines12:18 The Future of Interventional Psychiatry13:23 Emerging Technologies: Neurofeedback and Focused Ultrasound17:15 Building a Comprehensive Interventional Program18:13 Tools vs. Understanding Brain CircuitsWatch Insights on Psychiatry on YouTubeExecutive Producer: Jon Earle

To kick off Season 4, Charles Marmar, MD, explains how precision psychiatry is reshaping the way clinicians and researchers think about diagnosis, treatment selection, and the underlying biology of psychiatric disorders. This conversation is a overview of where the field stands today—including emerging molecular markers, biologically informed subtypes, and new translational approaches inspired by oncology and other precision-based specialties.Dr. Marmar is Chair of Psychiatry at NYU Grossman School of Medicine, and Director of the Center for the Study of Alcohol Use Disorder and Traumatic Stress.In this episode, he outlines current work on:Molecular and genomic signatures that may distinguish patient subtypesClinical trials examining targeted treatments for alcohol use disorderThe development of proxy “brain biopsy” methods such as exosomal analyses and iPSC-derived organoidsHow converging biological data could eventually support more individualized treatment planningThis discussion reflects ongoing efforts at NYU Langone Health to move psychiatry toward a more mechanism-based, biologically grounded model of care, while acknowledging the complexity and early stage of the work. For clinicians, scientists, and trainees, the episode provides a clear snapshot of the major directions shaping precision psychiatry today.CHAPTERS00:00 Introduction: The Challenge in Psychiatry00:34 Meet the Experts01:07 Understanding PTSD: Types and Subtypes04:47 Current Research and Innovations06:19 The Future of Psychiatry: Precision Medicine09:34 Case Study: Personalized Treatment Success11:33 Conclusion: The Path ForwardVisit our website for more Insights on Psychiatry.Watch this episode on YouTubeExecutive Producer: Jon Earle

About 805,000 people in the U.S. have a heart attack each year – and the experience doesn’t end in the ER. Recovery is a long-term process. We spoke to Harmony R. Reynolds, MD, director of both the Center for Women’s Cardiovascular Health and the Cardiovascular Clinical Research Center at NYU Langone Health, about the signs and symptoms to watch for, what healthy recovery can look like, how to support yourself or a loved one after a heart attack, and the key lifestyle changes that make a lasting difference.See omnystudio.com/listener for privacy information.

Vaginal dryness is one of the most common—and least discussed—health issues women face as they age. But here's the good news: it's completely treatable, and with the FDA's recent decision to remove the black box warning on vaginal estrogen, it's finally time for women to get the clear, accurate information they deserve.  In this episode, I sit down with Dr. Margaret Nachtigall, reproductive endocrinologist at NYU Langone Health, and one of the leading experts in women's midlife health, to break down exactly what's happening in the body, why symptoms often get misdiagnosed as infections, and how women can feel comfortable and empowered choosing the right treatment.  Whether you're experiencing symptoms now or simply want to understand your options, this is a must-listen conversation about taking over charge of your vaginal health—without stigma, confusion, or fear.  What We Cover  Why some women experience vaginal dryness—and why some don't  The role estrogen plays in vaginal health and why symptoms worsen time  How vaginal dryness symptoms can mimic infections  Why ruling out infection is essential before starting treatment  What the FDA's removal of the black box warning on vaginal estrogen means for women  The full menu of treatment options: moisturizers, lubricants, and hormonal therapies  Why more years without estrogen increases the likelihood of dryness  How to talk to your clinician and advocate for your own vaginal health  Why education and proactive care are key to healthier aging  Connect With  Barbara:   Have ideas for future episodes? We'd love to hear from you!   - Email: agebetterpodcast@gmail.com   - Connect on Instagram HERE   Learn more about your ad choices. Visit megaphone.fm/adchoices

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Aasma Shaukat, MD, MPH Blood-based colorectal cancer screening is entering a new era with FDA-approved and emerging tests like Shield and Simple Screen. Alongside updated stool-based options such as Cologuard Plus and CRC-PREVENT, clinicians now have a broader landscape of noninvasive tools to consider and discuss with their patients. Joining Dr. Peter Buch to talk about current recommendations and potential future directions for colorectal cancer screening is Dr. Aasma Shaukat. Dr. Shaukat is the Robert M. and Mary H. Glickman Professor of Medicine and a Professor of Population Health at NYU Grossman School of Medicine, as well as the Director of Outcomes Research in the Division of Gastroenterology and Hepatology at NYU Langone Health. She's also a co-author of a recent review on blood tests for colorectal cancer.

In this episode of SHE MD Podcast, Dr. Thaïs Aliabadi and Mary Alice Haney sit down with Dr. Tania Elliott to discuss allergies, immune health, and how hormonal changes impact symptoms. They explore practical strategies to reduce allergy triggers at home, boost immune health naturally, and adopt a personalized approach to allergy care. Dr. Elliott shares insights on seasonal allergies, food allergies, and hidden allergens in daily life, while providing actionable guidance for women navigating hormonal shifts during pregnancy, menopause, or with birth control. Listen to gain evidence-based tips to improve overall health, enhance quality of life, and take control of their wellness journey. Subscribe to SHE MD Podcast for expert tips on PCOS, Endometriosis, fertility, and hormonal balance. Share with friends and visit SHE MD Podcast and Ovii for research-backed resources, holistic health strategies, and expert guidance on women's health and well-being.Sponsors:Saje: Visit Saje.com to purchase plant powered products to remedy your needs. Use Code ‘SHEMD' for 20% off sitewide and free shippingOpill: Opill is birth control in your control, and you can use code SHEMD for twenty five percent off your first month of Opill at Opill.com.iRestore: For a limited time, get a HUGE discount on the iRESTORE Elite + Illumina Face Mask Bundle with code SHEMD at iRestore.comMerit: It's time to simplify your morning (Alt: Ready to simplify your routine?). Head to meritbeauty.com and get their Signature Makeup Bag free with your first order.Peloton: Let yourself run, lift, sculpt, push, and go. Explore the new Peloton Cross Training Tread+ at onepeloton.comGetJoy: As a listener of SheMD, you'll get 50% off your first subscription order of Get Joy's Freeze Dried Raw Dog Food plus two exclusive gifts: a free scoop and a 4oz bag of treats. Shop getjoyfood.com/shemd to support your dog's gut health and overall wellnessProlon: For a limited time, you can be first in line to experience the new Next Gen at special savings. Prolon is offering SHE MD listeners 15% off sitewide plus a $40 bonus gift when you subscribe to their 5-Day Program!Cymbiotika: Go to Cymbiotika.com/Shemd for 20% off plus free shippingWhat You'll LearnUnderstanding how seasonal allergies, food allergies, and intolerances differHow hormonal changes impact allergy symptoms in womenStrategies to reduce allergy triggers at home and boost immune health naturallyWhen to use at-home allergy tests safely versus consulting a professionalKey Timestamps(02:42) Dr. Tania Elliott's Introduction (05:23) Dr. Elliott's journey in allergy and immunology(08:45) Common myths about allergies and immune health(13:10) Actionable tips: reducing triggers, hormonal considerations, lifestyle adjustments(22:24) Understanding seasonal vs. food allergies and intolerances(28:05) Hormonal shifts affecting immune system and allergies in women(35:58) Microplastics and toxins(49:29) Top 3 lifestyle changes to reduce allergens and improve healthKey Takeaways Seasonal allergies, food allergies, and intolerances affect women differently, especially during hormonal changesHidden allergens in everyday life can trigger reactions without noticeLifestyle factors like sleep, stress, and gut health influence immune resiliencePersonalized allergy care is more effective than one-size-fits-all approachesAt-home allergy tests can be helpful but professional guidance is essential for accurate diagnosisGuest BioDr. Tania Elliott is a dual board-certified physician specializing in Internal Medicine and Allergy/Immunology. She serves as a Clinical Instructor at NYU Langone Health and is a spokesperson for the American College of Allergy, Asthma, and Immunology. Dr. Elliott empowers people to take control of their health through actionable advice and personalized care. She is also the founder of Modern Medical, a consulting firm providing strategic support across healthcare sectors.Links:

NYU Langone Health's Patient Experience Book Club demonstrates how simple, low-cost initiatives can foster meaningful connections among health care workers while improving professional well-being and institutional engagement through shared reading experiences.

In our October episode, we spoke with Dr. Samantha Dunham, co-director of the Center for Midlife Health and Menopause at NYU Langone Health, who shared important information about this unique stage in women's health journeys. In this month's Key Note, Dr. Dunham explains how women are taking control of their health and details simple lifestyle changes that can offer relief from menopause symptoms and boost overall wellness.   The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Get started on your health journey by making an appointment with your primary care physician to know your numbers. It's Breast Cancer Awareness Month: Women 40 and older – schedule a mammogram. Under 40 and unsure of your risk – ask your doctor about the screening schedule that's right for you. Visit our Healthy Living Resource Center for additional information and resources: 1199SEIUBenefits.org/healthyminds/ Find a mental health therapist through the Benefit Funds' Provider Directory: 1199SEIUBenefits.org/find-a-provider. For additional support, call our Wellness Member Assistance Program: (646) 473-6900. For more information and resources, visit The Menopause Society Menopause.org Get inspired by fellow members through our Members' Voices series: www.1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to view webinars on managing stress, building healthy meals and more: www.1199SEIUBenefits.org/videos. Visit our YouTube Channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists Sample our wellness classes to exercise body and mind: www.1199SEIUBenefits.org/wellnessevents.   Guest Bio Dr. Samantha Dunham is a certified menopause practitioner and co-director of the Center for Midlife Health and Menopause at NYU Langone Health. She practices general gynecology and preventative women's health, with a special focus on perimenopause and menopause and the role they play in disease development. At the Center for Midlife Health and Menopause, she educates patients on what to expect through perimenopause and menopause, and partners with them to develop a treatment plan that aligns with their symptoms and goals for treatment. Dr. Dunham completed residency in obstetrics and gynecology at New York University, and has been a board-certified physician for NYU Langone Health since 2006.  

Welcome, listeners, to "Ozempic Weightloss Unlocked," your source for the latest updates on Ozempic, from its medical origins to how it's changing lives and health conversations around the globe.Ozempic, with semaglutide as its active ingredient, was originally created to help manage type two diabetes by controlling blood sugar with a weekly injection. Novo Nordisk, a major pharmaceutical company, launched it in the United States in 2017 for diabetes, and then in higher doses as Wegovy in 2021 for chronic weight management. Its remarkable ability to suppress appetite and slow digestion quickly caught attention far beyond the diabetes community. According to researchers and clinical trials cited by Sky Lakes Health System and leading endocrinologists, Ozempic often results in an average weight loss of 15 to 20 percent of someone's starting body weight over a little more than a year. That means someone weighing two hundred pounds could expect around thirty pounds lost, sometimes even more. This is a level of weight loss that, until recently, was thought possible only through weight loss surgery.Medical experts, such as Dr. Bhattacharya, highlight not just the weight loss but also improvements in blood sugar control, lowered blood pressure, improved cholesterol, reduced inflammation, and even reduced rates of cardiovascular disease. Some studies suggest beneficial effects on sleep apnea and fatty liver disease, while users have reported quieter minds when it comes to food cravings. According to research presented by Novo Nordisk, over sixty percent of people taking Ozempic said they had fewer intrusive thoughts about food, which makes sticking to lifestyle changes easier for many listeners.However, listeners, this rapid adoption and results do not come without caveats. Experts at NYU Langone Health caution that the weight loss from Ozempic pales in comparison to bariatric surgery, which is about five times more effective over two years. Also, real-world results often underperform clinical trials because people stop the drug early, use too low a dose, or struggle to tolerate side effects. NYU Langone researchers found that up to seventy percent quit taking Ozempic and similar drugs within a year, possibly leading to weight regain.Now to the side effects, which are crucial for listeners to understand. Digestive system issues are by far the most common, with forty percent of users experiencing nausea, about a quarter dealing with diarrhea, and up to twenty percent reporting either constipation or vomiting. Most of these issues occur in the early weeks or after a dose increase and tend to ease with time. But, about seven percent stop the drug because of the severity of these symptoms, and there have been rare but serious cases of dehydration, gallbladder problems, kidney stress, and even vision changes such as sudden vision loss. There is also emerging evidence that Ozempic, especially when used long-term outside diabetes care, can rarely be associated with pancreatitis or changes in thyroid tissue, though the latter is mainly seen in animal studies. A 2025 study, reported in the journal Nature, found an increased risk of hair loss—particularly among women—which adds another risk to the picture.Listeners should know compounded versions of semaglutide are not the same as name-brand Ozempic. Compounded drugs may have inconsistent dosing or purity, and medical experts recommend the FDA-approved version whenever possible.It's important to stress that these medications work best alongside diet and lifestyle changes. Weight loss does not always equal better health if sleep, stress, movement, or other health factors are neglected. As Dr. Decker recommends, Ozempic is a powerful tool, not a magic solution, and may need to be taken long-term to keep the pounds off.To wrap up, Ozempic and similar medications are turning the tide for many who struggle with both diabetes and obesity. The benefits are real, but so are the risks and the importance of realistic expectations. Always consult your doctor before starting or continuing these medications, and monitor your body closely while using them.Thank you for tuning in to "Ozempic Weightloss Unlocked." Make sure to subscribe so you never miss an update. This has been a quiet please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Each year, more than 1 million women in the U.S. will experience menopause. And four out of five of those women will complain of symptoms that range from hot flashes and night sweats to sexual problems and sleep disturbances. In the not-so-distant past, menopause wasn't taken seriously, and women were hard-pressed to find answers to their questions. Thankfully, that's changing. To learn more about this unique aspect of women's health, we're joined by Dr. Samantha Dunham, a certified menopause practitioner and co-director of the Center for Midlife Health and Menopause at NYU Langone Health. Dr. Dunham explains the physical and emotional changes women experience during menopause – and perimenopause – and offers hope to those searching for treatment options to find relief from nagging symptoms and to protect their overall health.   The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Get started on your health journey by making an appointment with your primary care physician to know your numbers. It's Breast Cancer Awareness Month: Women 40 and older – schedule a mammogram. Under 40 and unsure of your risk – ask your doctor about the screening schedule that's right for you. Visit our Healthy Living Resource Center for additional information and resources: 1199SEIUBenefits.org/healthyminds/ Find a mental health therapist through the Benefit Funds' Provider Directory: 1199SEIUBenefits.org/find-a-provider. For additional support, call our Wellness Member Assistance Program: (646) 473-6900. For more information and resources, visit The Menopause Society Menopause.org Get inspired by fellow members through our Members' Voices series: www.1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to view webinars on managing stress, building healthy meals and more: www.1199SEIUBenefits.org/videos. Visit our YouTube Channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists Sample our wellness classes to exercise body and mind: www.1199SEIUBenefits.org/wellnessevents.   Guest Bio Dr. Samantha Dunham is a certified menopause practitioner and co-director of the Center for Midlife Health and Menopause at NYU Langone Health. She practices general gynecology and preventative women's health, with a special focus on perimenopause and menopause and the role they play in disease development. At the Center for Midlife Health and Menopause, she educates patients on what to expect through perimenopause and menopause, and partners with them to develop a treatment plan that aligns with their symptoms and goals for treatment. Dr. Dunham completed residency in obstetrics and gynecology at New York University, and has been a board-certified physician for NYU Langone Health since 2006.  

Welcome to Ozempic Weightloss Unlocked, where we dive into the latest breakthroughs and controversies surrounding Ozempic, its medical use, and its impact on everyday wellness.The big headline this month is the arrival of a new pill form of semaglutide, the main ingredient in Ozempic. According to The New England Journal of Medicine, people who took this daily pill lost almost 14 percent of their body weight over 64 weeks, compared to just 2 percent for those on a placebo. Fifty percent of the patients shed at least 15 percent of their weight, with nearly a third losing 20 percent or more. Novo Nordisk, the company that makes Ozempic, announced even stronger results for those who stuck to their treatment plan, with close to 17 percent average weight loss. This pill, pending approval, could be a game changer for people who prefer not to take injections.On the injectable front, clinical trials featured in The Lancet indicate that a higher 7.2 milligram weekly dose of semaglutide in adults without diabetes led to almost 19 percent average weight loss, higher than what's seen with lower doses. These numbers highlight ongoing efforts to increase the effectiveness of Ozempic for those struggling with obesity.Yet, it's crucial to balance these promising results with real-world insights. The Mayo Clinic and NYU Langone Health recently compared Ozempic's results to traditional weight loss surgery, like gastric bypass and sleeve gastrectomy. Their research revealed that surgery is five times more effective than GLP-1 drugs such as Ozempic, with surgical patients losing an average of 58 pounds after two years versus just 12 pounds for those on the drug for six months. Experts also noted that only 30 percent of patients stick with GLP-1 drugs for longer than a year, and real-world weight loss may be lower than trial results suggest. Surgery, however, isn't without its risks, including potential infections, blood clots, and hernias, and requires strict diet and lifestyle changes afterward.Turning to genetics, Cleveland Clinic research shows that the effectiveness of Ozempic may depend on your DNA. A specific variant in the Neurobeachin gene seems to make some people much more responsive to these medications, leading to 82 percent higher odds of substantial weight loss. This new insight could help doctors tailor treatments so patients get therapies most suited to their genetic profile.Lifestyle stakes are high, and so are concerns about side effects and safety. Recent studies report that Ozempic may cause severe conditions such as gastroparesis, bowel blockages, pancreatic and kidney injuries, and vision problems. Even hair loss is emerging as a potentially significant side effect, especially for women—according to recent findings, female users experienced about twice the rate of hair loss compared to those not using Ozempic.Because of these risks, there are currently over two thousand active lawsuits against Novo Nordisk and other GLP-1 manufacturers, with ongoing multidistrict litigation. These lawsuits allege that the companies did not give enough warning about the dangers, and some patients claim life-changing or life-threatening complications.Compounded GLP-1 drugs, made in pharmacies rather than by pharmaceutical companies, became popular when Ozempic was in short supply. However, the FDA warns that compounded drugs can be risky because they're not evaluated for safety or effectiveness. While the shortage has officially ended, compounded formulations remain in circulation.If you are considering Ozempic—whether as a pill, injection, or a compounded version—talk with your healthcare provider and review your health history, genetic background, and lifestyle goals. Widespread interest has led to changing availability, promising new forms, and more transparent labeling, especially after recent updates about kidney and pancreatic risks.To sum up, Ozempic continues to make waves as both a treatment for diabetes and a potent tool for weight loss. With fresh news about new pill forms, higher effective doses, genetic influences, and ongoing legal cases, it's important to stay informed and make choices based on both science and your personal health needs.Thanks for tuning in to Ozempic Weightloss Unlocked. Don't forget to subscribe to stay up to date on the latest developments. This has been a Quiet Please production, for more check out quiet please dot ai. Some great Deals https://amzn.to/49SJ3QsFor more check out http://www.quietplease.aiThis content was created in partnership and with the help of Artificial Intelligence AI

Wondering about whether large language models (generative AI) like ChatGPT, Co-Pilot or Claude, to name just a few, could add value to your clinical practice? Drs Mark Vorensky and Daniel Peredo (Rutgers University; NYU Langone Health) discuss the field of 'prompt engineering' - the approach to structuring and crafting the instructions (a.k.a. prompt) given to a generative AI model, to describe the task that the AI should perform. The quality of the output from generative AI is highly dependent on how the model is prompted. So, if you're looking to get the best out of generative AI, tune in! ------------------------------ RESOURCES Improving ChatGPT's performance using the CRISPE framework: https://www.jospt.org/doi/10.2519/josptmethods.2025.0151 Neck pain clinical practice guideline: https://www.jospt.org/doi/10.2519/jospt.2017.0302

NT is a 55-year-old man admitted to the general medicine service with cellulitis of his left leg. When the attending sees him the morning after admission, he notices the patient's “Medical Center Trustee” hospital ID on his bedside table. After gathering a history and examining the leg, the attending leaves the room. In the hallway, he crosses paths with the hospital president, who is there to make a “social call”. She smiles and says to the attending, “Don't let anything bad happen.”Sensible Medicine is reader-supported. If you appreciate our work, consider becoming a free or paid subscriber.Every clinician is familiar with the Very Important Patient, the VIP. Defining the VIP is challenging. In the most general sense, the VIP is a patient whose care imposes an additional burden on the clinician. The VIP is perceived to have an elevated social status, typically due to fame, wealth, connections, or power.The VIP may come to his or her status in several ways. The VIP might claim that status herself. The status might be granted by a third party, such as the source of the referral, or outside realities (fame, fortune, power). Sometimes, VIP status is granted by the physician alone.The physician recognizes that an untoward outcome in the care of the VIP — clinical or otherwise, expected or unexpected — will be acknowledged by a wider community and might be particularly unpleasant for the treating physician.VIP patients are a threat to healthcare. They need to be eradicated from hospitals and clinics as ruthlessly as we would eradicate E. coli from a well, Pseudomonas from a hot tub, or Legionella from a hotel HVAC system.Why should we eliminate the VIP? Because a patient's wealth, station, or connections should have no bearing on the tests that are done, the treatments that are offered, or the haste with which care is provided.I have heard people argue about whether basic healthcare is a human right. I have heard people who agree that basic healthcare is a human right argue about what makes up basic healthcare and who should decide what qualifies. I have never heard people argue about whether people deserve different care based on their identity.The most obvious threat the VIP poses is to himself. We recognize that when people are treated as special, they are at risk of getting worse healthcare. This fact underlies the guidance that physicians avoid caring for close friends and relatives. The AMA Code of Medical Ethics states:When the patient is an immediate family member, the physician's personal feelings may unduly influence his or her professional medical judgment. Or the physician may fail to probe sensitive areas when taking the medical history or to perform intimate parts of the physical examination. Physicians may feel obligated to provide care for family members despite feeling uncomfortable doing so. They may also be inclined to treat problems that are beyond their expertise or training.You could easily replace family member with VIP. While we can all avoid treating family members and close friends, VIPs are a reality in every physician's life. Transferring their care to another physician usually does not change the circumstances.Ben Kean, an exceptionally colorful character and my parasitology teacher in medical school, shared a story about the risks VIP healthcare poses to the VIP. He once suggested that a patient with pneumonia — a patient who was also famous, wealthy, and important — be transferred from a private hospital to a public one, and treated under a pseudonym."But why a public hospital, when I have a good private clinic here with the best doctors and nurses?""There are two ingredients essential to your recovery," I explained, "that can't be found here and that you cannot buy. These are things found only at a large public institution, where hundreds of patients are seen each day, many of whom suffer from pneumonia. First, you need a large house staff -- bright, young people with new ideas and with daily experience in dealing with desperate situations. Second, you need a laboratory with specialized technicians available around the clock to monitor your breathing, to do special culture work for bacteria and parasites. This is a lovely private hospital, but the kind of help you need isn't available here."Then there is the reality that if you treat VIPs differently, and it becomes known, it is a bad look. Just ask the leadership of NYU Langone Health.But the threat of the VIP goes beyond personal risk. The overtesting, overtreatment, and early diagnosis that have been described not only threaten the VIP but are also bad for our healthcare system. Overspending and excess erode other people's care. An unnecessary MRI ordered for the VIP's week of sciatica may delay the diagnosis of cord compression in the non-VIP with back pain and prostate cancer.VIP treatment can lead to ill will among members of the healthcare team. Teams bond when they work together for the benefit of a patient. With VIPs, team members most under the patient's sway may suggest management at odds with that proposed by team members less influenced by the patient's status. It is not hard to imagine moral injury if a healthcare worker perceives they are acting because of who a patient is rather than because of what the patient needs.If a team bows to pressure, the ethics of medicine are compromised. Other patients will perceive a tiered system, and this will undermine their faith in medicine.Eradicating the VIP from healthcare is certainly more difficult than getting rid of E. coli, Pseudomonas, or Legionella. How do we ensure that the homeless man, with no wealth, power, or family, receives the same care as the woman for whom the hospital is named?It may be hard to eradicate the VIP when healthcare itself has played a significant role in creating the VIP. Hospital marketing and rankings promote the idea that doctors and hospitals are not equal. They do this to attract the “best payer mix” so they can build shiny new facilities. If patients, with their expensive, private insurance, are drawn to a medical center because of the rankings, should we be surprised if they expect something for their money and effort?I wish there were an easy answer. There is not. It is possible that Mick and Keith are our best guides here.As clinicians, we know that we need to provide the best care possible for our patients. We also recognize that different people want different things from their healthcare. Some people just want to be left alone at night, others want an extra cup of tea with breakfast, and others want a visit from the hospital president. If these allowances truly do not affect the care of patients, all patients, then there is no harm in providing the desired care in addition to the necessary care. Once management of the VIP threatens to affect care, hers or that of her fellow patients, then physicians need to recommit to their pledge to care for everyone equally, regardless of who they are. This is at the core of the practice of medicine. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit www.sensible-med.com/subscribe

Eighty percent of us will develop fibroids by age 50–making them an epidemic nobody talks about. Tennis legend Venus Williams, 45, has recently spoken up about the debilitating pain, fatigue, and heavy bleeding she suffered with due to fibroids for literally decades. This week we talk with the doctor who finally helped her find relief, Dr. Taraneh Shirazian, Founder and Director of the Center for Fibroid Care at NYU Langone Health. We shine some much needed light on what fibroids are, common symptoms, how fibroids intersect with perimenopause, menopause, and hormone therapy, and what we can do about them. Dr. Taraneh Shirazian is the Founder and Director of the Center for Fibroid Care at NYU Langone Grossman School of Medicine, a state-of-the-art wellness center that takes a holistic, multidisciplinary approach to treating fibroids, abnormal uterine bleeding, and pelvic pain while prioritizing patients' life goals, including family planning. A minimally invasive gynecologic surgeon and Associate Professor at NYU Langone, she also directs Global Women's Health in OBGYN and at NYU's College of Global Public Health, where she has taught for seven years. She is the Founder and President of Saving Mothers, a nonprofit dedicated to reducing preventable maternal deaths worldwide. Recognized as a leader in women's health and an advocate for patient education and empowerment, Dr. Shirazian specializes in fibroids, endometriosis, ovarian cysts, pelvic pain, and abnormal bleeding, and is frequently featured as a women's health expert on major media outlets including CBS, CNN, The Today Show, Good Morning America, Newsweek, and The Wall Street Journal. You can follow her on Instagram @drshirazianResources:Venus Williams Opens Up About Her 30-Year Fibroids Journey, Self MagazineVenus Williams Shares Her Journey with Uterine Fibroids & Advocates for Women's Health, NYU Langone Health NewsHubSign up for our FREE Feisty 40+ newsletter: https://feistymedia.ac-page.com/feisty-40-sign-up-pageLearn More and Register for our Feisty 40+ Strong Retreat: https://www.womensperformance.com/strongretreat Learn More and Register for our 2026 Tucson Bike Camp: https://www.girlsgonegravel.com/camp Follow Us on Instagram:Feisty Menopause: @feistymenopause Hit Play Not Pause Facebook Group: https://www.facebook.com/groups/807943973376099 Support our Partners:Phosis: Use the code FEISTY15 for 15% off at https://www.phosis.com/ Midi Health: You Deserve to Feel Great. Book your virtual visit today at https://www.joinmidi.com/Previnex: Get 15% off your first order with code HITPLAY at https://www.previnex.com/ Nutrisense: Go to nutrisense.io/hitplay and use code: HITPLAY to get 30% offWahoo KICKR RUN: Use the code FEISTY to get a free Headwind Smart Fan (value $300) with the purchase of a Wahoo KICKR RUN at https://shorturl.at/maTzL This podcast uses the following third-party services for analysis: Spotify Ad Analytics - https://www.spotify.com/us/legal/ad-analytics-privacy-policy/Podcorn - https://podcorn.com/privacyPodscribe - https://podscribe.com/privacy

In this powerful and practical episode of The Dude Therapist, Eli Weinstein sits down with licensed clinical psychologist, keynote speaker, and burnout expert Dr. Jessica B. Stern to unpack the toxic traps of hustle culture—and how to escape them.Together, they explore what it really means to be “productive” in a way that aligns with your personal values, mental health, and life goals. Dr. Stern shares her insights on non-toxic productivity, the power of saying no, and how to work smarter without losing yourself in the process.Whether you're an overwhelmed parent, an ambitious professional, or just someone tired of feeling behind, this episode offers actionable tools and mindset shifts to help you find balance and thrive.Non-Toxic Productivity: Why hustle culture is harmful—and what to do insteadValues-Based Living: How aligning your work with personal values reduces burnoutThe Power of Saying No: Setting boundaries to prioritize what truly mattersMental Fitness Tips: Real-life strategies to reset your mindset and productivity habitsReframing Success: How to measure achievement beyond output and accoladesDr. Jessica Stern is a licensed clinical psychologist, keynote speaker, and founder of Three Lemons LLC, a wellness and corporate consulting firm. She's a clinical assistant professor at NYU Langone Health, radio host on SiriusXM, and advisor for Wondermind, the mental fitness company co-founded by Selena Gomez.With over a decade of experience, Dr. Stern is known for making complex mental health concepts relatable, accessible, and actionable. She's passionate about helping people ditch burnout, boost well-being, and live with greater clarity and purpose.Website: drjessicabstern.comInstagram: @drjessicabsternProductivity Course: Mayhem to Magic

Coming up on this episode of Flirtations, we're talking practical optimism and how this grounded, science-backed approach can help guide us toward more fulfilling connections and loving relationships. Joining us for this conversation is Dr. Sue Varma, a board-certified psychiatrist, clinical assistant professor at NYU, and the author of Practical Optimism: The Art, Science, and Practice of Exceptional Well-Being. Her work has helped countless people navigate trauma, stress, and uncertainty—and today, she's helping us bring more purpose and emotional resilience into our dating lives. In this conversation, we unpack what it really means to be optimistic in a world that doesn't always make it easy. We talk about why it's so hard to be alone, but how we can do just that without giving in to loneliness.  We explore how we can stop comparing ourselves to other people, how we can find purpose in small, everyday moments, and why empathy is so important to true, genuine connection. We also ask questions like, "Is happiness a choice?" "Can we train our brains to think bigger and love deeper?" And, "What does it mean to be a practical optimist?" If you're struggling to keep the hope alive out there dating or are having a hard time believing in yourself, you don't want to miss this episode! Dr. Varma's work has sincerely changed my own life in my longtime battle with depression and I hope that by the end of this episode, if you're having a hard time in your life, things will get just a bit easier. Alright Flirties, let's do this, and meet Dr. Sue Varma! Don't forget to subscribe, rate, and review Flirtations on your favorite podcast platform, and share this episode to spread BFE - big flirt energy, all over the world! Enjoying the show and want to support my work? Buy the Flirt Coach a coffee! About our guest:  Dr. Sue Varma is a board-certified psychiatrist and distinguished fellow of the American Psychiatric Association, with over 20 years of experience in both private practice and as a clinical assistant professor at NYU Langone Health. A trailblazer in her field, she was the inaugural medical director of NYU's 9/11 mental health program, earning a Mayoral Proclamation for her groundbreaking contributions. Dr. Varma is a highly sought-after keynote speaker and national medical commentator, regularly featured on leading platforms like the Today Show, Good Morning America, CBS Mornings, The NY Times, WSJ, Washington Post, along with documentaries and primetime specials, where her expertise has earned her 13 nominations and two Sharecare Emmy Awards. Honored as one of the world's top five leading health experts by Global Citizen for her pandemic work, and the Ivan Goldberg Award for Outstanding Service, Dr. Varma now brings her insights on mental wellness to a global audience with her acclaimed book Practical Optimism: The Art, Science, and Practice of Exceptional Wellbeing, being translated in a dozen languages and counting. To learn more about Dr. Varma and her work, please check out Instagram and www.drsuevarma.com. About your host:  Benjamin is a flirt and dating coach sharing his love of flirting and BFE - big flirt energy - with the world! A lifelong introvert and socially anxious member of society, Benjamin now helps singles and daters alike flirt with more confidence, clarity, and fun! As the flirt is all about connection, Benjamin helps the flirt community (the Flirties!) date from a place that allows the value of connection in all forms - platonic, romantic, and with the self - to take center stage. Ultimately, this practice of connection helps flirters and daters alike create stronger relationships, transcend limiting beliefs, and develop an unwavering love for the self. His work has been featured in Fortune, NBC News, The Huffington Post, Men's Health, and Yoga Journal. You can connect with Benjamin on Instagram, TikTok, stream the Flirtations Flirtcast everywhere you listen to podcasts (like right here!), and find out more about working together 1:1 here.

Show Notes What does it mean to practice “informative care” in the hospital setting—and how can rehab providers help patients undergoing cancer treatment stay strong throughout their hospitalization? In this episode, we speak with Galen Schram, PT, DPT, a board-certified clinical specialist in oncologic physical therapy and faculty member of the Acute Care PT Residency Program at NYU Langone Health. Galen shares his journey into acute care, his passion for serving hematology/oncology patients, and how he leverages interdisciplinary collaboration to support patients across phases of survivorship—including during hematopoietic stem cell transplant (HSCT). We also touch on his background in narrative medicine, and how storytelling can enhance connection and meaning in clinical work.

Dr. Steven Flanagan, a nationally renowned expert in the field of traumatic brain injury (TBI), has worked at the Rusk Rehabilitation Institute at NYU Langone Health since 2008. He serves as the Howard A. Rusk Professor of Rehabilitation Medicine and Chairperson of the Department of Rehabilitation Medicine at NYU Grossman School of Medicine. A former President of the American Academy of Physical Medicine & Rehabilitation (PM&R), he is certified by the American Board of PM&R (Brain Injury Medicine). A graduate of the University of Medicine & Dentistry of New Jersey, he completed his medical residency at Mt. Sinai Medical Center/Cabrini, Rehabilitation. Part 3 The discussion covered the following topics: social prescribing, artificial intelligence, reducing length of hospital stay, hospital readmission of patients, and implications of an obesity epidemic.

Dr. Robert Grossman, CEO of NYU Langone Health, spoke to At Barron's about how the health system has transformed and changes he made along the way. Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Steven Flanagan, a nationally renowned expert in the field of traumatic brain injury (TBI), has worked at the Rusk Rehabilitation Institute at NYU Langone Health since 2008. He serves as the Howard A. Rusk Professor of Rehabilitation Medicine and Chairperson of the Department of Rehabilitation Medicine at NYU Grossman School of Medicine. A former President of the American Academy of Physical Medicine & Rehabilitation (PM&R), he is certified by the American Board of PM&R (Brain Injury Medicine). A graduate of the University of Medicine & Dentistry of New Jersey, he completed his medical residency at Mt. Sinai Medical Center/Cabrini, Rehabilitation. Part 2 The discussion covered the following topics: Rusk's interprofessional approach to patient care, future hiring needs, health promotion efforts to enhance health of staff, preparing Rusk residents for the future in health care, and putting patients first.  

A conversation with Dr. Megan MorrisHow do we define quality of life? And how do we provide quality healthcare?These are key questions in the work of Dr. Megan Morris, a health services researcher, speech-language pathologist, and Associate Professor in the Department of Rehabilitation Medicine at NYU Langone Health.Dr. Morris is focused on addressing structural and interpersonal ableism in the American healthcare system - today she reveals just how far behind we are in the journey toward equity and accessibility.———We spoke about how ableism impacts patient care, why documenting disability status is crucial in our mission to improve quality of care, some of the changes occurring within the system, and what it would take to make healthcare truly inclusive for everyone. Follow me on Instagram and Facebook @ericfethkemd and checkout my website at www.EricFethkeMD.com. My brand new book, The Privilege of Caring, is out now on Amazon! https://www.amazon.com/dp/B0CP6H6QN4

Dr. Steven Flanagan, a nationally renowned expert in the field of traumatic brain injury (TBI), has worked at the Rusk Rehabilitation Institute at NYU Langone Health since 2008. He serves as the Howard A. Rusk Professor of Rehabilitation Medicine and Chairperson of the Department of Rehabilitation Medicine at NYU Grossman School of Medicine. A former President of the American Academy of Physical Medicine & Rehabilitation (PM&R), he is certified by the American Board of PM&R (Brain Injury Medicine). A graduate of the University of Medicine & Dentistry of New Jersey, he completed his medical residency at Mt. Sinai Medical Center/Cabrini, Rehabilitation. Part 1 The discussion covered the following topics: his involvement at Rusk in patient care, research, and professional organizations; impact of COVID on Rusk; traumatic brain injury biomarkers; and recruitment and retention of health professionals.      

Over the weekend, 45-year-old Mohamed Sabry Soliman was arrested and accused of using a makeshift flamethrower to target Jewish individuals in Boulder, Colorado. This incident follows the recent fatal shooting at a Jewish museum in Washington, D.C. Trey Gowdy, a former federal prosecutor, former South Carolina Congressman, and host of Sunday Night in America, joins to discuss the incident and the alarming rise of antisemitic incidents in the United States. An estimated 7.2 million Americans aged 65 and older now live with Alzheimer's. According to the Alzheimer's Association, one in three older adults dies with some form of dementia. Research surrounding the disease is rapidly evolving, with over 100 potential new treatments in the pipeline. Dr. Joel Salinas, Chief Medical Officer for Isaac Health and clinical associate professor at NYU Langone Health, joins the Rundown to discuss the progress being made in fighting Alzheimer's, including a new blood test that can help detect it early. Plus, commentary from the host of “Tomi Lahren is Fearless on Outkick,”  Learn more about your ad choices. Visit podcastchoices.com/adchoices

Story at-a-glance Nearly 40 million Americans take statins daily, yet these drugs don't fix the root cause of high cholesterol and often cause serious side effects like muscle pain and insulin resistance Dr. Adriana Quinones-Camacho, a cardiologist at NYU Langone Health, recommends lifestyle changes — like eating clean fats, exercising, and losing weight — as first-line treatments before resorting to risky cholesterol-lowering medications Eliminating processed seed oils and consuming whole-food omega-3s from fatty fish (in optimal amounts) will help improve your lipid profile and support natural cholesterol clearance through liver and cell function Excess weight raises low-density lipoprotein (LDL) levels and leads to plaque buildup in arteries; reducing sugar, increasing fiber, and adding daily movement reverses this damage and promotes long-term cardiovascular health Statins are linked to diabetes, cataracts, muscle breakdown, and depleted CoQ10, making lifestyle changes not only safer but also more effective for lasting heart and metabolic health

There's a care model for schizophrenia that actually works—why isn't it everywhere? On this episode, W. Gordon Frankle, MD, MBA, Vice Chair of Psychiatry at NYU Langone Health, shares how his team in Brooklyn is building a new model for treating serious mental illness—one rooted in long-term, relationship-driven, team-based care. From wraparound services to precision psychiatry, this conversation explores what happens when you bring humanity, structure, and innovation to a population too often left behind.Also discussed:The first novel schizophrenia drug in over 50 years (Cobenfy)Why clozapine is underused—and how that may finally changeThe potential of brain imaging and biomarkers in psychiatric treatmentWhat a real community mental health system looks likeWhy trust, not just treatment, is essential for recovery

Dr. Ezra Schwartz (@ezraschwartz10) interviews Dr. Firas Moussa and Mr. Jake Howitt to discuss the IMPROVE-AD Trial, a landmark, multi-institutional study investigating treatment strategies for uncomplicated Type B Aortic Dissection (uTBAD). The IMPROVE-AD Trial is a multicenter randomized trial funded by the NIH/NHLBI that compares thoracic endovascular aortic repair (TEVAR) plus optimal medical therapy (OMT) vs. OMT and surveillance with selective TEVAR in patients with uncomplicated TBAD. The trial aims to address critical gaps in evidence left by prior studies (INSTEAD-XL, ADSORB), with a unique focus on quality of life, cost-effectiveness, and genetic data. Dr. Firas Mussa is a professor and the Chief of Vascular and Endovascular Surgery at McGovern Medical School at UTHealth Houston. He previously served as the Director of the Vascular Surgery Residency and Fellowship programs at NYU Langone Health. Dr. Mussa earned his medical degree from the University of Baghdad, followed by general surgery training at Johns Hopkins University and a vascular surgery fellowship at Baylor College of Medicine. His research focuses on complex aortic pathology, and he serves as the principal investigator of the IMPROVE AD trial. Mr. Jake Howitt is the Community Engagement Co-Chair of the IMPROVE AD trial and a leading patient advocate within the PCORI-funded Aortic Dissection Collaborative. As a survivor of aortic dissection, he is passionate about improving patient-provider communication and raising awareness of hereditary aortic disease. His work emphasizes the importance of education, empathy, and community-building in clinical research and care delivery. Special thank you to Jacob Soucy (@JacobWSoucy). Resources: ·       Treatment of Uncomplicated Type B Aortic Dissection: Optimal Medical Therapy vs TEVAR + Optimal Medical Therapy- https://journals.sagepub.com/doi/10.1177/15385744231184671?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed  ·       INSTEAD Trial - https://pubmed.ncbi.nlm.nih.gov/19996018/ ·       INSTEAD-XL 5-Year Follow-Up - https://pubmed.ncbi.nlm.nih.gov/23922146/ ·       ADSORB Trial - https://pubmed.ncbi.nlm.nih.gov/24962744/ ·       Feasibility of a proposed randomized trial in patients with uncomplicated descending thoracic aortic dissection: Results of worldwide survey - https://pubmed.ncbi.nlm.nih.gov/27823685/ ·       Treatment of AD: Meta-Analysis - https://pubmed.ncbi.nlm.nih.gov/29066151/ ·       TEVAR vs Medical Therapy- https://pubmed.ncbi.nlm.nih.gov/36334259/ ·       IMPROVE AD Trial website - https://improvead.org ·       John Ritter Foundation for Aortic Health - https://johnritterfoundation.org ·       Think Aorta US - https://thinkaorta.us   Follow us @audiblebleeding Learn more about us at https://www.audiblebleeding.com/about-1/ and provide us with your feedback with our listener survey.  *Gore is a financial sponsor of this podcast, which has been independently developed by the presenters and does not constitute medical advice from Gore. Always consult the Instructions for Use (IFU) prior to using any medical device.      

Today, I have the pleasure of connecting with Dr. Sue Varma. Dr. Varma is a privately-practicing board-certified psychiatrist and a Clinical Assistant Professor of Psychiatry at New York University. She is a nationally acclaimed keynote speaker, medical contributor, media consultant, and advisor to leading television networks and programs. In our discussion today, we examine the impact of shared life experiences like 9/11 and the pandemic, exploring the role of PTSD and the effects of practical optimism, self-care, and self-reliance. We discuss optimism, its inheritability, and the significance of milestones for women, including transitioning from high school to college, navigating midlife, and addressing feelings of loneliness. We also look into purpose and compassion, the complexities of processing emotions, the challenges of the perfectionism façade, the role of trauma, ACE scores, autoimmunity, and the benefits of mindfulness and meditation.  Stay tuned for more! IN THIS EPISODE YOU WILL LEARN: Dr. Varma discusses the collective sense of grief, fear, connection, and empathy after 9/11 and the pandemic The importance of optimism and resilience when dealing with tragedy How Dr. Varma helps her patients identify their blind spots and other areas for improvement in their lives How perimenopause can bring about a sexual awakening and increased desire for intimacy but also loneliness and dissatisfaction in relationships Why friendships are essential for our well-being Why do we need to invest in different types of connections and relationships? The critical importance of finding purpose in life  How unprocessed emotions affect our mental and physical well-being How trauma impacts mental health Some practical tips for incorporating mindfulness into daily life  The benefits of meditation Bio: Dr. Sue Varma is a board-certified psychiatrist in private practice and a Clinical Assistant Professor of Psychiatry at New York University (NYU) Langone Health. She is a Distinguished Fellow of the American Psychiatric Association. Dr. Varma was the first medical director and attending psychiatrist at the World Trade Center Mental Health Program at NYU Langone Health, treating civilians and first responders in the aftermath of 9/11. Dr. Varma is a nationally acclaimed keynote speaker, medical contributor, media advisor, and consultant to major networks and shows. She regularly appears on the Today Show, Nightly News, CBS Mornings, and Good Morning America and is frequently interviewed by Time, Washington Post, NPR, and beyond. Dr. Varma is the recipient of numerous prestigious awards for her ground-breaking efforts in mental health education and advocacy, including a Sharecare Emmy. Her forthcoming book, “Practical Optimism,” is eagerly anticipated worldwide, with translations in several languages. Connect with Cynthia Thurlow Follow on Twitter Instagram LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Connect with Dr. Sue Varma On her website Instagram Facebook Twitter LinkedIn Dr. Varma's book, Practical Optimism:  The Art, Science, and Practice of Exceptional Well-Being

Vaping and vein health! Covid and clots! Easy bruising! Movie blood! Spider veins! Free socks! The heroic vascular surgeon Dr. Sheila Blumberg of NYU Langone Health let me ask her one million questions about how blood gets from point A to B all day. She explains the difference between arteries, veins, capillaries, and vessels and we cover everything from fainting to teenage movie tropes, how to tie a tourniquet, atherosclerosis, aneurysms, stents and why your leg is asleep right now. View Dr. Blumberg's publications on ResearchGateA donation went to BreakingGround.orgMore episode sources and linksSmologies (short, classroom-safe) episodesOther episodes you may enjoy: Diabetology (BLOOD SUGAR), Field Trip: My Butt, Colonoscopy Ride Along, Functional Morphology (ANATOMY), Hematology (BLOOD), Surgical Oncology (BREAST CANCER), Biogerontology (AGING), Proptology (THEATER & FILM PROPS), Vampirology (VAMPIRES)Sponsors of OlogiesTranscripts and bleeped episodesBecome a patron of Ologies for as little as a buck a monthOlogiesMerch.com has hats, shirts, hoodies, totes!Follow Ologies on Instagram and BlueskyFollow Alie Ward on Instagram and TikTokEditing by Mercedes Maitland of Maitland Audio Productions and Jake ChaffeeManaging Director: Susan HaleScheduling Producer: Noel DilworthTranscripts by Aveline Malek Website by Kelly R. DwyerTheme song by Nick Thorburn